Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» New Enrollment in FAME II Halted After Interim Analysis Shows Benefits of FFR
New Enrollment in FAME II Halted After Interim Analysis Shows Benefits of FFR
New Enrollment in FAME II Halted After Interim Analysis Shows Benefits of FFR
Submitted by
moderatorj
on January 18, 2012 - 9:44pm
Source:
Forbes
News Tags:
clinical trials
St. Jude Medical
Headline:
New Enrollment in FAME II Halted After Interim Analysis Shows Benefits of FFR
Do Not Allow Advertisers to Use My Personal information
